Clinical Trial Update: Is Intralymphatic Allergen Immunotherapy Effective and Safe? [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on intralymphatic allergen immunotherapy for allergic rhinitis due to grass pollen; completed phases 2 and 3 to assess effectiveness and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Due to Grass Pollen

Drugs mentioned

• Intralymphatic allergen immunotherapy (intralymphatic allergen immunotherapy)

Snippet

Sponsor: Lars Olaf Cardell | Conditions: Allergic Rhinitis Due to Grass Pollen | Phase 2, Phase 3 | Status: COMPLETED